barr 513 Pill - orange capsule/oblong, 23mm
Pill with imprint barr 513 is Orange, Capsule/Oblong and has been identified as Acetazolamide Extended Release 500 mg. It is supplied by Teva Pharmaceuticals USA.
Acetazolamide is used in the treatment of Glaucoma; Hydrocephalus; Edema; Epilepsy; Mountain Sickness / Altitude Sickness and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for barr 513
Acetazolamide Extended Release
- Imprint
- barr 513
- Strength
- 500 mg
- Color
- Orange
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants, Carbonic anhydrase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00555-0513 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
sodium lauryl sulfate,
magnesium silicate,
D&C Red No. 28,
D&C Yellow No. 10,
FD&C Red No. 40,
gelatin,
titanium dioxide,
aluminum oxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
shellac,
propylene glycol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
See also:
More about acetazolamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (192)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- AcetaZOLAMIDE, acetaZOLAMIDE Sodium monograph
- Acetazolamide (FDA)
- Acetazolamide Capsules (FDA)
- Acetazolamide Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.